[Photo] CEO Lee Woo-seok Silent on 'Invossa Incident' Questions
Lee Woo-seok, CEO of Kolon Life Science, who is suspected of being involved in the controversy surrounding the osteoarthritis gene therapy drug 'Invossa K Injection (Invossa)', is attending the pre-arrest suspect interrogation (warrant hearing) held on the 31st at the Seoul Central District Court in Seocho-gu, Seoul. / Reporter Moon Ho-nam munonam@
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] Lee Targets Samsung Electronics Union: "Collective Bargaining Should Not Be Abused... There Is an Appropriate Limit"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.